
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
AAIPharma Completes CAC Acquisition
Wilmington, N.C., October 26, 2006--AAIPharma Inc. announced today that it has completed the previously announced acquisition of Cvitkovic & Associès Consultants S.A. (CAC), an international contract research organization specializing in oncology drug development and medical consulting. CAC has clinical operations in France, Croatia, Russia, Spain, Argentina, Peru, Australia, and the United States. As a result of the acquisition, CAC has become the foundation of AAIOncology, a global business unit dedicated to oncology drug development.






